Enhancing the endogenous EPO/EPOR system through exogenous EPO administration could provide crucial protection against neurological damage induced by pathological Aβ and tau protein aggregates or other neurotoxic factors implicated in AD pathogenesis [50]. This evidence concerns the gene EPO and Alzheimer disease.